BAGEDA
Back to Products20 mg
| Form | Tablets |
|---|---|
| Active Substance | Leflunomide |
| Presentation | 30 Tablets |
| Treatment Category | Musculoskeletal system |
SPC
BAGEDA
SPC — PDF
CORPORATE
WMR&D
- WMR&D CENTER
- SCIENCE DEPARTMENT
-
PRODUCT DEVELOPMENT AND TECHNOLOGY TRANSFER
- WMINOLAB
BUSINESS STRATEGY
PRESS
-
WORLD MEDICINE IN PRESS
- PRESS RELEASES
- PRESS CENTER
- CORPORATE VIDEOS